Medicare Enrolled
Dr. Basil Younes, D.O.
Cardiovascular Disease · Torrance, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Younes from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Younes?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Younes
Dr. Basil Younes is a cardiovascular disease specialist in Torrance, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Younes performed 6,328 Medicare services across 3,167 unique beneficiaries.
Between the years covered by Open Payments, Dr. Younes received a total of $15,473 from 51 pharmaceutical and/or device companies across 609 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Younes is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 14% volume in CA
$15,473 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,328
Medicare services
Top 14% in CA for cardiovascular disease
3,167
Unique beneficiaries
$105
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~352 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
1,772 | $99 | $131 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,224 | $101 | $160 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
510 | $144 | $275 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
486 | $66 | $92 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
378 | $177 | $315 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
377 | $7 | $36 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
337 | $42 | $255 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
271 | $12 | $76 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
225 | $155 | $893 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
138 | $131 | $270 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
91 | $55 | $277 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
85 | $403 | $1,572 |
| Pacemaker system evaluation Assessment of a pacemaker device, including single, dual, multiple lead, or leadless systems. |
67 | $48 | $107 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
59 | $149 | $250 |
| Cardiac catheterization | 53 | $180 | $875 |
| Coronary stent placement A procedure to insert a stent into a coronary artery or its branch to keep it open, using balloon dilation during the process. |
36 | $470 | $4,400 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
36 | $21 | $150 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
36 | $787 | $1,025 |
| Ultrasound of heart blood vessel or graft An ultrasound exam to evaluate blood flow in a heart blood vessel or graft, including a radiologist's review of the initial vessel. |
28 | $76 | $485 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
20 | $18 | $60 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
20 | $12 | $60 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
20 | $111 | $429 |
| Transesophageal echocardiogram An ultrasound of the heart performed using a probe inserted into the esophagus to obtain detailed images of heart structures and function. |
17 | $89 | $420 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
16 | $10 | $50 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 14 | $289 | $1,375 |
| Intravascular ultrasound of heart vessel, initial An ultrasound procedure used to evaluate a blood vessel within the heart during a diagnostic or treatment procedure. |
12 | $58 | $150 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
6.0% high complexity
9.6% medium
84.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$15,473
Total received (2018-2024)
Avg $2,210/year across 7 years
Top 21% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
609
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,455 (99.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$19 (0.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,493
2023
$3,558
2022
$3,020
2021
$2,250
2020
$1,218
2019
$1,578
2018
$1,357
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABIOMED
$384
Boston Scientific Corporation
$346
Alnylam Pharmaceuticals Inc.
$227
Kestra Medical Technology Services, Inc.
$166
Merck Sharp & Dohme LLC
$161
Kiniksa Pharmaceuticals International, plc
$160
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$126
Medtronic, Inc.
$94
Boehringer Ingelheim Pharmaceuticals, Inc.
$86
Abbott Laboratories
$84
Bayer Healthcare Pharmaceuticals Inc.
$82
Janssen Pharmaceuticals, Inc
$82
Novo Nordisk Inc
$79
AstraZeneca Pharmaceuticals LP
$78
Amgen Inc.
$77
Lilly USA, LLC
$63
Inari Medical, Inc.
$53
AltaThera Pharmaceuticals LLC
$26
SCPHARMACEUTICALS INC.
$26
E.R. Squibb & Sons, L.L.C.
$19
PFIZER INC.
$18
Novartis Pharmaceuticals Corporation
$18
Cook Medical LLC
$18
Penumbra, Inc.
$17
Top 3 companies account for 38.4% of 2024 payments
All-time payments by company (2018-2024) ›
ABIOMED
$2,095
Novartis Pharmaceuticals Corporation
$1,580
Abbott Laboratories
$1,299
AstraZeneca Pharmaceuticals LP
$746
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$723
PFIZER INC.
$718
Amgen Inc.
$668
SANOFI-AVENTIS U.S. LLC
$579
Boehringer Ingelheim Pharmaceuticals, Inc.
$569
Kestra Medical Technology Services, Inc.
$489
Alnylam Pharmaceuticals Inc.
$486
Boston Scientific Corporation
$484
E.R. Squibb & Sons, L.L.C.
$462
Merck Sharp & Dohme LLC
$455
Novo Nordisk Inc
$438
Cardiovascular Systems Inc.
$409
Janssen Pharmaceuticals, Inc
$372
ShockWave Medical, Inc
$286
Merck Sharp & Dohme Corporation
$255
Impulse Dynamics (USA) Inc.
$215
Shockwave Medical, Inc
$214
Lilly USA, LLC
$167
Kiniksa Pharmaceuticals International, plc
$160
Regeneron Healthcare Solutions, Inc.
$146
Medtronic, Inc.
$126
Bard Peripheral Vascular, Inc.
$109
Venclose Inc.
$108
Amarin Pharma Inc.
$107
Inari Medical, Inc.
$104
BIOTRONIK INC.
$99
SCPHARMACEUTICALS INC.
$89
Bayer Healthcare Pharmaceuticals Inc.
$82
Medtronic Vascular, Inc.
$69
Itamar Medical Inc
$66
Edwards Lifesciences Corporation
$64
CSL Behring
$63
Kiniksa Pharmaceuticals, Ltd.
$49
Stryker Corporation
$37
Tactile Systems Technology Inc
$35
CHIESI USA, INC.
$30
Akcea Therapeutics, Inc.
$29
AltaThera Pharmaceuticals LLC
$26
Baxter Healthcare
$23
Aziyo Biologics, Inc.
$22
Teleflex LLC
$20
Cook Medical LLC
$18
Arrow International, Inc.
$18
Penumbra, Inc.
$17
Allergan Inc.
$16
Lexicon Pharmaceuticals, Inc.
$16
ACIST MEDICAL SYSTEMS, INC.
$14
Top 3 companies account for 32.1% of all-time payments
Associated products mentioned in payments ›
AMVUTTRA · AVEIR · AVVIGO Guidance System · Acticor · Arcalyst · Assure WCD · BIOMONITOR · BRILINTA · BYSTOLIC · CAMZYOS · CHANTIX · CONFIRM RX · COROFLOW · Catheter - GuideLiner · Confirm Rx · Corlanor · Coronary Orbital Atherectomy System · DRAGONFLY OPSTAR · ECM Patch · ELIQUIS · ENTRESTO · EVRSF · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FLEXITOUCH · FLOWTRIEVER CATHETER · FUROSCIX · Flexitouch Plus · GENERAL THERAPIES · GENERAL VASCULAR ACCESS · Hillrom - Carnation Ambulatory Monitor · Impella · Indigo System · Inpefa · Interventional Products · JARDIANCE · KENGREAL 50MG/10ML L · Kcentra · Kerendia · LEQVIO · LINQ II · LifeVest · MICRA · MOUNJARO · MULTAQ · NAVITOR · ONPATTRO · OPTIMIZER · Optis Coronary Imaging System · Ozempic · PASCAL · PRADAXA · PRALUENT · PROPEL · Pouch · QUADRA ASSURA · ROTAPRO · RXI SYSTEMS · Repatha · Reveal LINQ · S · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SURPASS EVOLVE · Sotalol Hydrochloride · TEGSEDI · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TRULICITY · VERQUVO · VIGILANT · VYNDAQEL · Vascepa · WAINUA · WatchPATONE · XARELTO · XIENCE SKYPOINT · Xience Alpine cornary stent system · Xience Sierra Coronary Stent · Xience Sierra Coronary Stent System · ZILVER PTX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
551
Per 100K population
5.6
County median income
$87,760
Nearest hospital
PROVIDENCE LITTLE COMPANY OF MARY MED CTR TORRANCE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Younes is a clinical cardiology specialist, with above-average Medicare volume (top 14% in CA), with low-engagement industry engagement, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Younes experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Younes performed 1,772 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Younes receive payments from pharmaceutical companies?
Yes. Dr. Younes received a total of $15,473 from 51 companies across 609 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Younes's costs compare to other cardiologists in Torrance?
Dr. Younes's average Medicare payment per service is $105. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Younes) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Torrance
Browse cardiologists in Torrance ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
ABIOMED Payments to Doctors
See all physicians who received payments from ABIOMED.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology